Cargando…

Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data

OBJECTIVE: The prediction of response to pharmacotherapy has not been sufficiently explored in children and adolescents with psychiatric disorders, which was addressed in this study. METHODS: Data from four double‐blind, placebo‐controlled studies (sertraline and fluvoxamine for anxiety disorders, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujii, Takashi, Sakurai, Hitoshi, Takeuchi, Hiroyoshi, Suzuki, Takefumi, Mimura, Masaru, Uchida, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773749/ https://www.ncbi.nlm.nih.gov/pubmed/36330567 http://dx.doi.org/10.1002/npr2.12299

Ejemplares similares

Effectiveness of Saikokaryukotsuboreito (Herbal Medicine) for Antipsychotic-Induced Sexual Dysfunction in Male Patients with Schizophrenia: A Description of Two Cases
por: Takashi, Tsuboi, et al.
Publicado: (2014)

Factor Structure of the Targeted Inventory on Problems in Schizophrenia
por: Tanaka, Shoji, et al.
Publicado: (2013)

Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross‐sectional study
por: Takahashi, Kie, et al.
Publicado: (2020)

Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series
por: Tani, Hideaki, et al.
Publicado: (2021)

Asymptomatic Deep Vein Thrombosis in a Patient with Major Depressive Disorder
por: Ishida, Takuto, et al.
Publicado: (2012)

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry
por: Sakurai, Hitoshi, et al.
Publicado: (2022)

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder
por: Nomura, Kensuke, et al.
Publicado: (2021)

Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey
por: Tani, Hideaki, et al.
Publicado: (2012)

Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies
por: Ueno, Fumihiko, et al.
Publicado: (2019)

Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)
por: Kitagawa, Kohei, et al.
Publicado: (2020)

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey
por: Nagai, Nobuhiro, et al.
Publicado: (2020)

PT594. Placebo effects in Alzheimer Disease: analysis of the CATIE-AD data
por: Ozawa, Chisa, et al.
Publicado: (2016)

PM398. Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia
por: Koizumi, Teruki, et al.
Publicado: (2016)

Epinephrine during resuscitation of traumatic cardiac arrest and increased mortality: a post hoc analysis of prospective observational study
por: Yamamoto, Ryo, et al.
Publicado: (2019)

PT567. Improvement to antipsychotic treatment at week 2 predicts subsequent treatment response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data
por: Yoshida, Kazunari, et al.
Publicado: (2016)

Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
por: Okubo, Ruri, et al.
Publicado: (2021)

PM388. Brain function measures of therapeutic effects of pharmacotherapy in schizophrenia: An fMRI study
por: Hasegawa, Sayaka, et al.
Publicado: (2016)

The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy
por: Iosifescu, Dan V, et al.
Publicado: (2016)

PS164. Concomitant Use of Benzodiazepine Hypnotics and Alcohol in Patients with Schizophrenia, Depression and Insomnia: A Preliminary Finding
por: Uchida, Takahito, et al.
Publicado: (2016)

Pharmacotherapy for anxiety disorders in children and adolescents
por: Kodish, Ian, et al.
Publicado: (2011)

Pharmacotherapy of pediatric and adolescent HIV infection
por: Schuval, Susan J
Publicado: (2009)

Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study
por: Nomura, Nobuyuki, et al.
Publicado: (2021)

Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
por: Rondepierre, Fabien, et al.
Publicado: (2023)

MRI predictors of pharmacotherapy response in major depressive disorder
por: Gerlach, Andrew R., et al.
Publicado: (2022)

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
por: Kitahata, Ryosuke, et al.
Publicado: (2017)

Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation
por: Kario, Kazuomi, et al.
Publicado: (2023)

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023)

Predictors of Quality of Life in Children and Adolescents with Psychiatric Disorders
por: Bastiaansen, Dennis, et al.
Publicado: (2019)

Assessment of pharmacists' self-reported preparedness to provide pharmacotherapy services to individuals with psychiatric disorders
por: German, Alexander, et al.
Publicado: (2018)

Inter-class Concomitant Pharmacotherapy in Medicaid-Insured Youth Receiving Psychiatric Residential Treatment
por: Edelsohn, Gail A., et al.
Publicado: (2021)

Melancholic and reactive depression: a reappraisal of old categories
por: Mizushima, Jin, et al.
Publicado: (2013)

Pharmacotherapy of Adolescent Alcohol and Other Drug Use Disorders
por: Solhkhah, Ramon, et al.
Publicado: (1998)

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
por: Ascher-Svanum, Haya, et al.
Publicado: (2013)

Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study
por: Tsuchida-Nishiwaki, Mariko, et al.
Publicado: (2021)

Cost‐effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy‐resistant depression at secondary mental health care settings
por: Sado, Mitsuhiro, et al.
Publicado: (2021)

Neuropathology of supercentenarians - four autopsy case studies
por: Takao, Masaki, et al.
Publicado: (2016)

Polygenic risk scores for major psychiatric and neurodevelopmental disorders contribute to sleep disturbance in childhood: Adolescent Brain Cognitive Development (ABCD) Study
por: Ohi, Kazutaka, et al.
Publicado: (2021)

Letter to the editor regarding the article “The use of Psychiatric Electroencephalography Evaluations Registry (PEER) to personalize pharmacotherapy”
por: Weina, Peter J, et al.
Publicado: (2017)

Design and methods of the ‘monitoring outcomes of psychiatric pharmacotherapy’ (MOPHAR) monitoring program – a study protocol
por: Simoons, Mirjam, et al.
Publicado: (2019)

Rates and correlates of pharmacotherapy-related problems among psychiatric inpatients: a representative Danish study
por: Kibsdal, Karina Porsborg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cn4telnujhvi5nq203vuasni7m